Informace o publikaci

Damage to ovarian functions in young women treated with ABVD and BEACOPP chemotherapy for Hodgkin lymfoma

Autoři

ŠMARDOVÁ Lenka KRÁL Zdeněk HUSER Martin CRHA Igor

Rok publikování 2005
Druh Konferenční abstrakty
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Popis Introduction: Depending on the type of the chemotherapy (CT) administered, premature ovarian failure develops in young women, causing clinical symptoms due to the lack of estrogens, and resulting in subsequent sterility. Objectives: Retrospective analysis of the fertility was made in female pts treated with the BEACOPP or ABVD and MOPP(COPP),ABVD CT. Methods: A total of 16 pts underwent the therapy based on the BEACOPP with baseline (n=6) or escal. doses (n=4), or a combination of 4 cycles of the baseline and escal. BEACOPP (n=6). A total of 32 pts were treated with CT in the past, namely using the ABVD (n=25) or the hybrid MOPP(COPP),ABVD alternating regimen (n=7). Results: 5/16 (31 %) of the pts reported oligomenorrhoea or complete amenorrhoea during the BEACOPP. After 6 months from the end of the therapy, half of the pts (n=8) did not menstruate. The menses disappeared during the ABVD or MOPP (COPP)/ABVD in 6/36 (19 %) of the pts. Conclusions: The BEACOPP poses a risk of early menopause and permanent sterility to young patients owing to the presence of several gonadotoxic agents.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info